DERM - Journey Medical Corporation (DERM) Q1 2024 Earnings Call Transcript
2024-05-13 22:43:09 ET
Journey Medical Corporation (DERM)
Q1 2024 Earnings Conference Call
May 14, 2024 04:30 PM ET
Company Participants
Jaclyn Jaffe - Senior Director, Corporate Operations
Claude Maraoui - Co-Founder, President and CEO
Joseph Benesch - Interim Chief Financial Officer
Dr. Srinivas Sidgiddi - Vice President, Research and Development
Ramsey Allous - General Counsel and Corporate Secretary
Conference Call Participants
Scott Henry - Alliance Global Partner
Kalpit - B. Riley Securities
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical's First Quarter 2024 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen only mode. [Operator Instructions]. A webcast replay of the call will be available approximately one hour after the end of the call for approximately 30 days.
I would now like to turn the call over to Jaclyn Jaffe, the company's Senior Director of Corporate Operations. Jaclyn, please go ahead.
Jaclyn Jaffe
Good afternoon and thank you for participating in today's conference call. Joining me from Journey Medical's leadership team are Claude Maraoui, Co-Founder, President and Chief Executive Officer, Joseph Benesch, Chief Financial Officer, Dr. Srinivas Sidgiddi, Vice President of Research and Development, and Ramsey Alloush, General Counsel and Corporate Secretary who will be joining for the Q&A portion of the call....
Journey Medical Corporation (DERM) Q1 2024 Earnings Call Transcript